Although mid-sized pharmaceutical companies have fallen behind in sales, but not in R&D

While research and development(R&D) of pharmaceutical companies have been accelerated, it is known that the ranking for R&D expenses against sales and their increase rates has been changed a number of times. It is analyzed, particularly, that mid-sized pharmaceutical companies have actively invested funds in R&D despite their small scale.

According to the YakupDotCom’s analysis result of R&D e...